跳至主要内容
临床试验/NCT00164008
NCT00164008已完成4 期

Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis

Bayside Health0 个研究点目标入组 56 人开始时间: 2002年10月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
56
主要终点
Bone mineral density of lumbar spine at 12 months as measured by DEXA.

研究概览

简要总结

The purpose of this trial is to see whether zoledronic acid is better than pamidronate to treat low bone density in heart and lung transplant patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • reduced bone density as indicated by a bone density T score <-1.in either the lumbar spine or femoral neck
  • have undergone or are on the waiting list for heart or lung transplantation
  • are receiving adequate calcium and vitamin D therapy
  • have provided written informed consent prior to participation in the trial

排除标准

  • untreated hypogonadism, hypothyroidism or hyperthyroidism
  • acute or major organ rejection or intercurrent illness
  • pregnancy or breastfeeding

结局指标

主要结局

Bone mineral density of lumbar spine at 12 months as measured by DEXA.

次要结局

  • Bone mineral density of femoral neck at 12 months as measured by DEXA.

研究者

发起方
Bayside Health
申办方类型
Other Gov
责任方
Sponsor

相似试验